The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures
Open accessAbstract
This document is complementary to an Expert Review Document on Optical Coherence Tomography (OCT) for the study of coronary arteries and atherosclerosis.1 The goal of this companion manuscript is to provide a practical guide framework for the appropriate use and reporting of the novel frequency domain (FD) OCT imaging to guide interventional procedures, with a particular interest on the comparison with intravascular ultrasound (IVUS).1–4 In the OCT Expert Review Document on Atherosclerosis, a comprehensive description of the physical principles for OCT imaging and time domain (TD) catheters (St Jude Medical, Westford, MA, USA) was provided.1 The main advantage of FD-OCT is that the technology enables rapid imaging of the coronary artery, using a non-occlusive acquisition modality. The FD-OCT catheter (DragonflyTM; St Jude Medical) employs a single-mode optical fibre, enclosed in a hollow metal torque wire that rotates at a speed of 100 r.p.s. It is compatible with a conventional 0.014″ angioplasty guide wire, inserted into a short monorail lumen at the tip. The frequency domain optical coherence tomography lateral resolution is improved in comparison with TD-OCT, while the axial resolution did not change. These features, together with reduced motion artefacts and an increased maximum field of view up to 11 mm, have significantly improved both the quality and ease of use of OCT in the catheterization laboratory.3,4 However, the imaging depth of the FD-OCT is still limited to 0.5–2.0 mm.5 The main obstacle to the adoption of TD-OCT imaging in clinical practice is that OCT cannot image through a blood field, and therefore requires clearing or flushing of blood from the lumen.1 The 6 Fr compatible DragonflyTM FD-OCT catheter is so far the only one in the market, as two other systems from Volcano and Terumo, which have function similar to the DragonflyTM, are not yet available. The DragonflyTM catheter is first advanced over a regular guide wire, distal to the region of interest. A dedicated marker, located 10 mm distal to the OCT lens, enables the pull-back starting point selection. The acquisition of an OCT image sequence requires a bolus of crystalloid solution (usually contrast) injected through the guiding catheter. The acquisition speed can be set up in a range between 5 and 40 mm/s, based on the used OCT system. Most expert users advocate the use of automated contrast injection to optimize the image quality. The previous experience with TD and FD-OCT technology shows OCT acquisition to be safe,1,4,6 effective,1,4,6–8 and highly reproducible for the assessment of the luminal areas and length.9–11 A fair correlation between OCT and IVUS quantitative measurements of the lumen areas was reported,9–11 despite comparative studies showing that IVUS tends to slightly overestimate lumen areas, while stent and neointimal areas are slightly higher on OCT.9–11 Frequency domain optical coherence tomography image quality depends on an accurate acquisition technique and proper guiding catheter engagement is needed to optimize directional contrast flushing. Metallic stent struts are highly reflective structures that lead to specular reflection with the excessive signal usually resulting in ‘blooming’ of the strut surface. Optical coherence tomography shows only the reflection of the luminal surface of the stent strut and is unable to provide a direct measurement of the strut thickness.8,12 Two features indicate a strut: a highly reflective spot and/or an associated shadow behind the strut. The presence of only one of these two defining features is sufficient for strut identification. For bioresorbable stents, the assessment of the whole thickness is possible, since light can usually penetrate non-metallic materials. They can be followed by serial images; the degradation process, characterized by the presence of empty spaces replacing stent struts, was documented for the first generation design,13 but was not visible with the second-generation model, which maintains its mechanical properties.14 Based on preliminary unpublished data, the bioabsorbable magnesium stent has different properties; it is visible after implantation and tends to disappear at the follow-up due to magnesium degradation. Stent overlap occurs in the cross sections in which two superimposed layers of stent struts are visible (Figure 1). Incomplete stent apposition or malapposition occurs if there is a separation of a stent strut from the vessel wall. Malapposition can be addressed at a cross-section level and expressed as an area, or can be evaluated at the strut level analysis.15 In the latter case, it is defined as a measured distance greater than the strut thickness for bare metal stents or greater than the sum of the thickness of the strut plus polymer for drug eluting stents (DES)8,15 (Figure 2). Acute malapposition is diagnosed immediately after stent deployment (Figure 1),14 late malapposition at the follow-up, while late acquired malapposition
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Prospective Natural-History Study of Coronary Atherosclerosis
Stone, G. W., Maehara, A., Lansky, A. J., de Bruyne, B., Cristea, E., Mintz, G. S., Mehran, R., McPherson, J., Farhat, N., Marso, S. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1002358 · Cited by 3,276
Self-citationPathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Mintz, G. S., Nissen, S. E., Anderson, W. D., Bailey, S. R., Erbel, R., Fitzgerald, P. J., Pinto, F. J., Rosenfield, K., Siegel, R. J., Tuzcu, E. M., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01175-5 · Cited by 2,185
Self-citationFinn, A. V., Joner, M., Nakazawa, G., Kolodgie, F., Newell, J., John, M. C., Gold, H. K., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.107.693739 · Cited by 1,277
Jang, I.-K., Bouma, B. E., Kang, D.-H., Park, S.-J., Park, S.-W., Seung, K.-B., Choi, K.-B., Shishkov, M., Schlendorf, K., Pomerantsev, E., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01799-5 · Cited by 1,000
Self-citationIn Vivo Characterization of Coronary Atherosclerotic Plaque by Use of Optical Coherence Tomography
Jang, I.-K., Tearney, G. J., MacNeill, B., Takano, M., Moselewski, F., Iftima, N., Shishkov, M., Houser, S., Aretz, H. T., Halpern, E. F., et al. (2005) · Circulation · doi:10.1161/01.cir.0000159354.43778.69 · Cited by 896
Self-citationPrati, F., Regar, E., Mintz, G. S., Arbustini, E., Di Mario, C., Jang, I.-K., Akasaka, T., Costa, M., Guagliumi, G., Grube, E., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp433 · Cited by 880
Self-citationSerruys, P. W., Ormiston, J. A., Onuma, Y., Regar, E., Gonzalo, N., Garcia-Garcia, H. M., Nieman, K., Bruining, N., Dorange, C., Miquel-Hébert, K., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60325-1 · Cited by 820
Self-citationQuantification of Macrophage Content in Atherosclerotic Plaques by Optical Coherence Tomography
Tearney, G. J., Yabushita, H., Houser, S. L., Aretz, H. T., Jang, I.-K., Schlendorf, K. H., Kauffman, C. R., Shishkov, M., Halpern, E. F., & Bouma, B. E. (2003) · Circulation · doi:10.1161/01.cir.0000044384.41037.43 · Cited by 704
Self-citationAssessment of Coronary Arterial Plaque by Optical Coherence Tomography
Kume, T., Akasaka, T., Kawamoto, T., Watanabe, N., Toyota, E., Neishi, Y., Sukmawan, R., Sadahira, Y., & Yoshida, K. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.035 · Cited by 573
Self-citation
Cited by
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
Self-citation(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
Self-citation2018 ESC/EACTS Guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · EuroIntervention · doi:10.4244/eijy19m01_01 · Cited by 1,259
Self-citation2018 ESC/EACTS Guidelines on myocardial revascularization
Sousa-Uva, M., Neumann, F.-J., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy289 · Cited by 989
Self-citationLight in diagnosis, therapy and surgery
Yun, S. H., & Kwok, S. J. J. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0008 · Cited by 793
Optical coherence tomography in coronary atherosclerosis assessment and intervention
Araki, M., Park, S.-J., Dauerman, H. L., Uemura, S., Kim, J.-S., Di Mario, C., Johnson, T. W., Guagliumi, G., Kastrati, A., Joner, M., et al. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00687-9 · Cited by 430
Self-citation2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0224 · Cited by 418
Self-citationPrati, F., Di Vito, L., Biondi-Zoccai, G., Occhipinti, M., La Manna, A., Tamburino, C., Burzotta, F., Trani, C., Porto, I., Ramazzotti, V., et al. (2012) · EuroIntervention · doi:10.4244/eijv8i7a125 · Cited by 381
Self-citationClinical Impact of OCT Findings During PCI
Prati, F., Romagnoli, E., Burzotta, F., Limbruno, U., Gatto, L., La Manna, A., Versaci, F., Marco, V., Di Vito, L., Imola, F., et al. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.08.013 · Cited by 360
Self-citationMeneveau, N., Souteyrand, G., Motreff, P., Caussin, C., Amabile, N., Ohlmann, P., Morel, O., Lefrançois, Y., Descotes-Genon, V., Silvain, J., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.024393 · Cited by 346
Self-citation2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m09_01 · Cited by 328
Self-citationSouteyrand, G., Amabile, N., Mangin, L., Chabin, X., Meneveau, N., Cayla, G., Vanzetto, G., Barnay, P., Trouillet, C., Rioufol, G., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv711 · Cited by 299
Self-citationKubo, T., Shinke, T., Okamura, T., Hibi, K., Nakazawa, G., Morino, Y., Shite, J., Fusazaki, T., Otake, H., Kozuma, K., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx351 · Cited by 288
Self-citation
Metadata
- Authors
- Prati, F., Guagliumi, G., Mintz, G. S., Costa, M., Regar, E., Akasaka, T., Barlis, P., Tearney, G. J., Jang, I.-K., Arbustini, E., Bezerra, H. G., Ozaki, Y., Bruining, N., Dudek, D., Radu, M., Erglis, A., Motreff, P., Alfonso, F., Toutouzas, K., Gonzalo, N., Tamburino, C., Adriaenssens, T., Pinto, F., Serruys, P. W. J., Di Mario, C., & Document, F. T. E. O. R.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-31
- Volume
- 33
- Issue
- 20
- Pages
- 2513-2520
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2050896619
- Cited by
- 400
- References
- 25
- FWCI
- 36.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.